Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma.
D000255:Adenosine Triphosphate; D000262:Adenylyl Cyclases / Q000378:metabolism*; D000310:Adrenal Gland Neoplasms / Q000201:enzymology*; D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology; D001665:Binding Sites; D002116:Calcitonin / Q000494:pharmacology; D002277:Carcinoma / Q000201:enzymology*; D002384:Catalysis; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003864:Depression, Chemical; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology*; D006801:Humans; D007986:Luteinizing Hormone / Q000494:pharmacology; D008297:Male; D008660:Metabolism / Q000187:drug effects; D008729:Methoxamine / Q000494:pharmacology; D009374:Neoplasms, Experimental / Q000201:enzymology; D009638:Norepinephrine / Q000494:pharmacology; D010281:Parathyroid Hormone / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010759:Phosphorus Isotopes; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic; D013268:Stimulation, Chemical; D013972:Thyrotropin / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D000588:Amines; D001593:Benzyl Compounds; D002395:Catecholamines; D006728:Hormones; D010281:Parathyroid Hormone; D010759:Phosphorus Isotopes; D011941:Receptors, Adrenergic; D014667:Vasopressins; D000255:Adenosine Triphosphate; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D002116:Calcitonin; D005934:Glucagon; D011433:Propranolol; D000262:Adenylyl Cyclases; D008729:Methoxamine; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine